Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according to research conducted by the Max Planck Institute for Heart and Lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback